References

  1. 1.Migliorini F, Marsilio E, Torsiello E, et al. Osteoarthritis in athletes versus nonathletes: a systematic review. Sports Med Arthrosc Rev. 2022;30(2):78-86.
  2. 2.Tibor LM, Ganz R. Hip osteoarthritis: definition and etiology. In: Nho SJ, Bedi A, Salata MJ, et al. Hip Arthroscopy and Hip Joint Preservation Surgery. 2nd ed. Springer; 2022:161-174.
  3. 3.Cross M, Smith E, Hoy D, et al. The global burden of hip and knee osteoarthritis: estimates from the global burden of disease 2010 study. Ann Rheum Dis. 2014;73(7):1323-1330.
  4. 4.Lawrence RC, Felson DT, Helmick CG, et al.; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. Arthritis Rheum. 2008;58(1):26-35.
  5. 5.Nho SJ, Kymes SM, Callaghan JJ, et al. The burden of hip osteoarthritis in the United States: epidemiologic and economic considerations. J Am Acad Orthop Surg. 2013;21(suppl 1):S1-S6.
  6. 6.Quintana JM, Arostegui I, Escobar A, et al. Prevalence of knee and hip osteoarthritis and the appropriateness of joint replacement in an older population. Arch Intern Med. 2008;168(14):1576-1584.
  7. 7.Kohn M, Sassoon A, Fernando N. Classifications in brief: Kellgren-Lawrence classification of osteoarthritis. Clin Orthop Relat Res. 2016;474(8):1886-1893.
  8. 8.Roemer FW, Guermazi A, Demehri S, et al. Imaging in osteoarthritis. Osteoarthritis Cartilage. 2022;30(7):913-934.
  9. 9.Liew JW, King LK, Mahmoudian A, et al.; OARSI Early Osteoarthritis Classification Criteria Task Force. A scoping review of how early-stage knee osteoarthritis has been defined. Osteoarthritis Cartilage. 2023;31(9):1234-1241.
  10. 10.Jordan JM, Helmick CG, Renner JB, et al. Prevalence of hip symptoms and radiographic and symptomatic hip osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project. J Rheumatol. 2009;36(4):809-815.
  11. 11.Katz JN, Arant KR, Loeser RF. Diagnosis and treatment of hip and knee osteoarthritis: a review. JAMA. 2021;325(6):568-578.
  12. 12.Lespasio MJ, Sultan AA, Piuzzi NS, et al. Hip osteoarthritis: a primer. Perm J. 2018;22:17-084.
  13. 13.Sharma L. Osteoarthritis of the knee. N Engl J Med. 2021;384(1):51-59.
  14. 14.Yingke X, Qing W. Trends and disparities in osteoarthritis prevalence among US adults, 2005-2018. Sci Rep. 2021;11(1):21845.
  15. 15.Hohmann E, Tetsworth K, Glatt V. Anterior cruciate ligament reconstruction results in better patient reported outcomes but has no advantage for activities of daily living or the subsequent development of osteoarthritis. A systematic review and meta-analysis. Knee. 2023;41:137-149.
  16. 16.Dhillon J, Kraeutler MJ, Belk JW, et al. Effects of running on the development of knee osteoarthritis: an updated systematic review at short-term follow-up. Orthop J Sports Med. 2023;11(3):23259671231152900.
  17. 17.Nha KW, Oh SM, Ha YW, et al. Radiological grading of osteoarthritis on Rosenberg view has a significant correlation with clinical outcomes after medial open-wedge high-tibial osteotomy. Knee Surg Sports Traumatol Arthrosc. 2019;27(6):2021-2029.
  18. 18.Hsu H, Siwiec R. Knee Arthroplasty. StatPearls Publishing, 2023. https://www.ncbi.nlm.nih.gov/books/NBK507914/
  19. 19.Bevers K, Bijlsma JW, Vriezekolk JE, et al. Ultrasonographic features in symptomatic osteoarthritis of the knee and relation with pain. Rheumatology (Oxford). 2014;53(9):1625-1629.
  20. 20.Innmann MM, Lunz A, Fröhlich L, et al. What is the correlation between clinical and radiographic findings in patients with advanced osteoarthritis of the knee? J Clin Med. 2023;12(16):5420.
  21. 21.Mourad C, Vande Berg B. Osteoarthritis of the hip: is radiography still needed? Skeletal Radiol. 2023;52(11):2259-2270.
  22. 22.Fox MG, Chang EY, Amini B, et al.; Expert Panel on Musculoskeletal Imaging. ACR Appropriateness Criteria® Chronic Knee Pain. J Am Coll Radiol. 2018;15(11S):S302-S312.
  23. 23.Sakellariou G, Conaghan PG, Zhang W, et al. EULAR recommendations for the use of imaging in the clinical management of peripheral joint osteoarthritis. Ann Rheum Dis. 2017;76(9):1484-1494.
  24. 24.Clausen S, Heerey J, Hartvigsen J, et al. Do imaging findings modify the effect of non-surgical treatment in patients with knee and hip osteoarthritis? A systematic literature review. BMJ Open. 2023;13(3):e065373.
  25. 25.Lim YZ, Wong J, Hussain SM, et al. Recommendations for weight management in osteoarthritis: a systematic review of clinical practice guidelines. Osteoarthr Cartil Open. 2022;4(4):100298.
  26. 26.French HP, Abbott JH, Galvin R. Adjunctive therapies in addition to land-based exercise therapy for osteoarthritis of the hip or knee. Cochrane Database Syst Rev. 2022(10):CD011915.
  27. 27.Hua J, Sun L, Teng Y. Effects of high-intensity strength training in adults with knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Am J Phys Med Rehabil. 2023;102(4):292-299.
  28. 28.Brophy RH, Fillingham YA. AAOS clinical practice guideline summary: Management of Osteoarthritis of the Knee (Nonarthroplasty), third edition. J Am Acad Orthop Surg. 2022;30(9):e721-e729.
  29. 29.Bannuru RR, Osani MC, Vaysbrot EE, et al. OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis. Osteoarthritis Cartilage. 2019;27(11):1578-1589.
  30. 30.Schnitzer TJ, Robinson RL, Viktrup L, et al. Opioid prescribing for osteoarthritis: cross-sectional survey among primary care physicians, rheumatologists, and orthopaedic surgeons. J Clin Med. 2023;12(2):589.
  31. 31.Kwak SG, Kwon JB, Seo YW, et al. The effectiveness of acupuncture as an adjunctive therapy to oral pharmacological medication in patient with knee osteoarthritis: a systematic review and meta-analysis. Medicine (Baltimore). 2023;102(11):e33262.
  32. 32.Chen PY, Song CY, Yen HY, et al. Impacts of tai chi exercise on functional fitness in community-dwelling older adults with mild degenerative knee osteoarthritis: a randomized controlled clinical trial. BMC Geriatr. 2021;21(1):449.
  33. 33.Dantas LO, Salvini TD, McAlindon TE. Knee osteoarthritis: key treatments and implications for physical therapy. Braz J Phys Ther. 2021;25(2):135-146.
  34. 34.Belk JW, Lim JJ, Keeter C, et al. Patients with knee osteoarthritis who receive platelet-rich plasma or bone marrow aspirate concentrate injections have better outcomes than patients who receive hyaluronic acid: systematic review and meta-analysis. Arthroscopy. 2023;39(7):1714-1734.
  35. 35.Belk JW, Kraeutler MJ, Houck DA, et al. Platelet-rich plasma versus hyaluronic acid for knee osteoarthritis: a systematic review and meta-analysis of randomized controlled trials. Am J Sports Med. 2021;49(1):249-260.
  36. 36.Xue Y, Wang X, Wang X, et al. A comparative study of the efficacy of intra-articular injection of different drugs in the treatment of mild to moderate knee osteoarthritis: a network meta-analysis. Medicine (Baltimore). 2023;102(12):e33339.
  37. 37.Trojian TH, Concoff AL, Joy SM, et al. AMSSM scientific statement concerning viscosupplementation injections for knee osteoarthritis: importance for individual patient outcomes. Br J Sports Med. 2016;50(2):84-92.
  38. 38.Pham T, van der Heijde D, Altman RD, et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage. 2004;12(5):389-399.
  39. 39.Daniels EW, Cole D, Jacobs B, et al. Existing evidence on ultrasound-guided injections in sports medicine. Orthop J Sports Med. 2018;6(2):2325967118756576
  40. 40.Singh J, Khan WS, Marwah S, et al. Do we need radiological guidance for intra-articular hip injections? Open Orthop J. 2014;8(1):114-117.
  41. 41.Yiannakopoulos C, Sachinis N, Oluku J, et al. Intra-articular hip injection using anatomical and radiological landmarks without the use of ultrasound or radiological guidance. Cureus. 2022;14(3):e23581.
  42. 42.Uson J, Rodriguez-García SC, Castellanos-Moreira R, et al. EULAR recommendations for intra-articular therapies. Ann Rheum Dis. 2021;80(10):1299-1305.
  43. 43.Finnoff JT, Awan TM, Borg-Stein J, et al. American Medical Society for Sports Medicine position statement: principles for the responsible use of regenerative medicine in sports medicine. Clin J Sport Med. 2021;31(6):530-541.
  44. 44.O’Connor D, Johnston RV, Brignardello-Petersen R, et al. Arthroscopic surgery for degenerative knee disease (osteoarthritis including degenerative meniscal tears). Cochrane Database Syst Rev. 2022(3):CD014328.
  45. 45.Couldrick JM, Woodward AP, Silva MDC, et al. Evidence for key individual characteristics associated with outcomes following combined first-line interventions for knee osteoarthritis: a systematic review. PLoS One. 2023;18(4):e0284249.
  46. 46.Nilsing Strid E, Ekelius-Hamping M. Experiences of sexual health in persons with hip and knee osteoarthritis: a qualitative study. BMC Musculoskelet Disord. 2020;21(1):576.
  47. 47.Hall M, Spiers L, Knox G, et al. Feasibility of exercise and weight management for people with hip osteoarthritis and overweight or obesity: a pilot study. Osteoarthr Cartil Open. 2021;3(3):100174.
  48. 48.Ayers DC, Yousef M, Yang W, et al. Age-related differences in pain, function, and quality of life following primary total knee arthroplasty: results from a FORCE-TJR (Function and Outcomes Research for Comparative Effectiveness in Total Joint Replacement) cohort. J Arthroplasty. 2023;38(7 suppl 2):S169-S176.
  49. 49.Sepucha KR, Vo H, Chang Y, et al. Shared decision-making is associated with better outcomes in patients with knee but not hip osteoarthritis: the DECIDE-OA randomized study. J Bone Joint Surg Am. 2022;104(1):62-69.
  50. 50.Ayers DC, Yousef M, Zheng H, et al. Do patient outcomes vary by patient age following primary total hip arthroplasty? J Arthroplasty. 2022;37(suppl 7):S510-S516.
  1. 1.Ryan SP, Stambough JB, Huddleston JI, et al. Highlights of the 2023 American Joint Replacement Registry annual report. Artzhroplast Today. 2024;26:101325.
  2. 2.American College of Rheumatology. Joint replacement surgery. https://rheumatology.org/patients/joint-replacement-surgery
  3. 3.Madry H. Surgical therapy in osteoarthritis. Osteoarthritis Cartilage. 2022;30(8):1019-1034.
  4. 4.Seidlitz C, Kip M. Chapter 1: introduction to the indications and procedures. In: Bleẞ HH, Kip M, eds. White Paper on Joint Replacement: Status of Hip and Knee Arthroplasty Care in Germany. Springer; 2018. https://www.ncbi.nlm.nih.gov/books/NBK546138/
  5. 5.Hsu H, Siwiec R. Knee Arthroplasty. StatPearls Publishing, 2023. https://www.ncbi.nlm.nih.gov/books/NBK507914/
  6. 6.Zhang Z, Shen B, Yang J, et al. Risk factors for venous thromboembolism of total hip arthroplasty and total knee arthroplasty: a systematic review of evidence in ten years. BMC Musculoskelet Disord. 2015;16:24.
  7. 7.Jansen E, Brienza S, Gierasimowicz-Fontana A, et al. Rehabilitation after total knee arthroplasty of hip and knee [in French]. Rev Med Brux. 2015;36(4):313-320.
  8. 8.Crawford RW, Murray DW. Total hip replacement: indications for surgery and risk factors for failure. Ann Rheum Dis. 1997;56(8):455-457.
  9. 9.Jasper LL, Jones CA, Mollins J, et al. Risk factors for revision of total knee arthroplasty: a scoping review. BMC Musculoskelet Disord. 2016;17:182.
  10. 10.Evans JT, Walker RW, Evans JP, et al. How long does a knee replacement last? A systematic review and meta-analysis of case series and national registry reports with more than 15 years of follow-up. Lancet. 2019;393(10172):655-663.
  11. 11.Arthritis Foundation. Pre-hab for surgery. https://www.arthritis.org/health-wellness/treatment/joint-surgery/preplanning/pre-hab-for-surgery
  12. 12.Palmer SH, Cross MJ. Total knee arthroplasty (TKA). https://emedicine.medscape.com/article/1250275-overview
  13. 13.Waterman BR, Belmont PJ, Bader JO, et al. The Total Joint Arthroplasty Cardiac Risk Index for predicting perioperative myocardial infarction and cardiac arrest after primary total knee and hip arthroplasty. J Arthroplasty. 2016;31(6):1170-1174.
  14. 14.Ayoade F, Li D, Mabrouk A, et al. Periprosthetic Joint Infection. StatPearls Publishing; 2004. https://www.ncbi.nlm.nih.gov/books/NBK448131/
  15. 15.Eka A, Chen AF. Patient-related medical risk factors for periprosthetic joint infection of the hip and knee. Ann Transl Med. 2015;3(16):233.
  16. 16.Rodriguez-Merchan EC, Delgado-Martinez AD. Risk factors for periprosthetic joint infection after primary total knee arthroplasty. J Clin Med. 2022;11(20):6128.
  17. 17.Goodman SM, Springer BD, Chen AF, et al. 2022 American College of Rheumatology/American Association of Hip and Knee Surgeons guideline for the perioperative management of antirheumatic medication in patients with rheumatic diseases undergoing elective total hip or total knee arthroplasty. Arthritis Rheumatol. 2022;74(9):1464-1473.
  18. 18.Sattler L, Hing W, Vertullo C. Changes to rehabilitation after total knee replacement. Aust J Gen Pract. 2020;49(9):587-591.
  19. 19.Anderson DR, Dunbar M, Murnaghan J, et al. Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. N Engl J Med. 2018;378(8):699-707.
  20. 20.Mody BS, Wadhwa M, Roy R, et al. Current evidence and expert opinion on thromboprophylaxis after total knee and hip replacement. Cureus. 2023;15(12):e51089.
  21. 21.Memtsoudis SG, Cozowicz C, Bekeris J, et al. Peripheral nerve block anesthesia/analgesia for patients undergoing primary hip and knee arthroplasty: recommendations from the International Consensus on Anesthesia-Related Outcomes after Surgery (ICAROS) group based on a systematic review and meta-analysis of current literature. Reg Anesth Pain Med. 2021;46(11):971-985.
  22. 22.Atwood K, Shackleford T, Lemons W, et al. Postdischarge opioid use after total hip and total knee arthroplasty. Arthroplast Today. 2021;7:126-129.
  23. 23.Bandholm T, Wainwright TW, Kehlet H. Rehabilitation strategies for optimisation of functional recovery after major joint replacement. J Exp Orthop. 2018;5(1):44.
  24. 24.Walker LC, Clement ND, Deehan DJ. Predicting the outcome of total knee arthroplasty using the WOMAC score: a review of the literature. J Knee Surg. 2019;32(8):736-741.
  25. 25.Winternitz W. Postoperative care for hip replacement. https://www.arthritis-health.com/surgery/hip-surgery/postoperative-care-hip-replacement
  26. 26.Repky S, Büchele G, Günther KP, et al. Five years’ trajectories of functionality and pain in patients after hip or knee replacement and association with long-term patient survival. Sci Rep. 2020;10(1):1-7.
  1. 1.Earwood JS, Walker TR, Sue GJC. Septic arthritis: diagnosis and treatment. Am Fam Physician. 2021;104(6):589-597.
  2. 2.Kaandorp CJE, Dinant HJ, van de Laar MAFJ, et al. Incidence and sources of native and prosthetic joint infection: a community based prospective survey. Ann Rheum Dis. 1997;56(8):470-475.
  3. 3.Mathews CJ, Weston VC, Jones A, et al. Bacterial septic arthritis in adults. Lancet. 2010;375(9717):846-855.
  4. 4.Weishaupt D, Schweitzer ME. MR imaging of septic arthritis and rheumatoid arthritis of the shoulder. Magn Reson Imaging Clin N Am. 2004;12(1):111-124.
  5. 5.Ross JJ. Septic arthritis of native joints. Infect Dis Clin North Am. 2017;31(2):203-218.
  6. 6.McBride S, Mowbray J, Caughey W, et al. Epidemiology, management, and outcomes of large and small native joint septic arthritis in adults. Clin Infect Dis. 2020;70(2):271-279.
  7. 7.Momodu II, Savaliya V. Septic Arthritis. Stat Pearls Publishing, 2023. https://www.ncbi.nlm.nih.gov/books/NBK538176/
  8. 8.Goldenberg D. Septic arthritis. Lancet. 1998;351(9097):197-202.
  9. 9.Kaandorp C, Van Schaardenburg D, Krijnen P, et al. Risk factors for septic arthritis in patients with joint disease. A prospective study. Arthritis Rheum. 1995;38(12):1819-1825.
  10. 10.Hassan AS, Rao A, Manadan AM, et al. Peripheral bacterial septic arthritis: review of diagnosis and management. J Clin Rheumatol. 2017;23(8):435-442.
  11. 11.Lieber SB, Fowler ML, Zhu C, et al. Clinical characteristics and outcomes in polyarticular septic arthritis. Joint Bone Spine. 2018;85(4):469-473.
  12. 12.Miller JM, Binnicker MJ, Campbell S, et al. Guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2024 update by the Infectious Diseases Society of America (IDSA) and the American Society for Microbiology (ASM). Clin Infect Dis. 2024:104.
  13. 13.Ungprasert P, Kaewpoowat Q, Ratapano S, et al. Presence of crystals is not an evidence of absence of infection. Am J Emerg Med. 2013;31(2):455.e1-455.e2.
  14. 14.Shirtliff ME, Mader JT. Acute septic arthritis. Clin Microbiol Rev. 2002;15(4):527-544.
  15. 15.Shapiro NI, Howell MD, Talmor D, et al. Serum lactate as a predictor of mortality in emergency department patients with infection. Ann Emerg Med. 2005;45(5):524-528.
  16. 16.Luo TD, Jarvis DL, Yancey HB, et al. Synovial cell count poorly predicts septic arthritis in the presence of crystalline arthropathy. J Bone Jt Infect. 2020;5(3):118-124.
  17. 17.Jokic A, et al. Laboratory testing of extravascular body fluids: national recommendations on behalf of the Croatian Society of Medical Biochemistry and Laboratory Medicine. Part II—synovial fluid. Biochem Med (Zagreb). 2020;30(3):030501.
  18. 18.Lim W, Barras CD, Zadow S. Radiologic mimics of osteomyelitis and septic arthritis: a pictorial essay. Radiol Res Pract. 2021;2021:9912257.
  19. 19.Patil P, Dasgupta B. Role of diagnostic ultrasound in the assessment of musculoskeletal diseases. Ther Adv Musculoskelet Dis. 2012;4(5):341-355.
  20. 20.Ravindran V, Logan I, Bourke BE. Medical vs surgical treatment for the native joint in septic arthritis: a 6-year, single UK academic centre experience. Rheumatology (Oxford). 2009;48(10):1320-1322.
  21. 21.Horowitz DL, Katzap E, Horowitz S, et al. Approach to septic arthritis. Am Fam Physician. 2011;84(6):653-660.
  22. 22.Gjika E, Beaulieu JY, Vakalopoulos K, et al. Two weeks versus four weeks of antibiotic therapy after surgical drainage for native joint bacterial arthritis: a prospective, randomised, non-inferiority trial. Ann Rheum Dis. 2019;78(8):1114-1121.
  23. 23.Bernard L, Arvieux C, Brunschweiler B, et al. Antibiotic therapy for 6 or 12 weeks for prosthetic joint infection. N Engl J Med. 2021;384(21):1991-2001.
  24. 24.Li HK, Rombach I, Zambellas R, et al.; OVIVA Trial Collaborators. Oral versus intravenous antibiotics for bone and joint infection. N Engl J Med. 2019;380(5):425-436.
  25. 25.Munoz G. Surgical treatment of septic arthritis: technique. https://emedicine.medscape.com/article/1268369-technique
  26. 26.Abram SGF, Alvand A, Judge A, et al. Mortality and adverse joint outcomes following septic arthritis of the native knee: a longitudinal cohort study of patients receiving arthroscopic washout. Lancet Infect Dis. 2020;20(3):341-349.
  27. 27.Tande AJ, Patel R. Prosthetic joint infection. Clin Microbiol Rev. 2014;27(2):302-345.
  28. 28.Parvizi J, Tan TL, Goswami K, et al. The 2018 definition of periprosthetic hip and knee infection: an evidence-based and validated criteria. J Arthroplasty. 2018;33(5):1309.e2-1314.e2.
  29. 29.Gupta A, Osmon DR, Hanssen AD, et al. Genitourinary procedures as risk factors for prosthetic hip or knee infection: a hospital-based prospective case-control study. Open Forum Infect Dis. 2015;2(3):ofv097.
  30. 30.Khashab MA, Chithadi KV, Acosta RD, et al.; ASGE Standards of Practice Committee. Antibiotic prophylaxis for GI endoscopy. Gastrointest Endosc. 2015;81(1):81-89.
  31. 31.Watters W, Rethman MP, Hanson NB, et al.; American Academy of Orthopedic Surgeons, American Dental Association. Prevention of orthopaedic implant infection in patients undergoing dental procedures. J Am Acad Orthop Surg. 2013;21(3):180-189.
  32. 32.Sollecito TP, Abt E, Lockhart PB, et al. The use of prophylactic antibiotics prior to dental procedures in patients with prosthetic joints: evidence-based clinical practice guideline for dental practitioners—a report of the American Dental Association Council on Scientific Affairs. J Am Dent Assoc. 2015;146(1):11.e8-16.e8.
  1. 1.Hua C, Daien CI, Combe B, et al. Diagnosis, prognosis and classification of early arthritis: results of a systematic review informing the 2016 update of the EULAR recommendations for the management of early arthritis. RMD Open. 2017;3(1):e000406.
  2. 2.Avouac J, Gossec L, Dougados M. Diagnostic and predictive value of anti-cyclic citrullinated protein antibodies in rheumatoid arthritis: a systematic literature review. Ann Rheum Dis. 2006;65(7):845-851.
  3. 3.Kay J, Upchurch KS. ACR/EULAR 2010 rheumatoid arthritis classification criteria. Rheumatology (Oxford). 2012;51(suppl 6):vi5-vi9.
  4. 4.American College of Rheumatology Subcommittee on Rheumatoid Arthritis Guidelines. Guidelines for the management of rheumatoid arthritis: 2002 update. Arthritis Rheum. 2002;46(2):328-346.
  5. 5.Bobek D, Banić Stipetić A, Franić M, et al. Use of non-steroidal anti-inflammatory drugs in patients with advanced active rheumatoid arthritis. Acta Clin Croat. 2022;61(4):588-598.
  6. 6.Fraenkel L, Bathon JM, England BR, et al. 2021 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021;73(7):924-939.
  7. 7.Humphrey MB, Russell L, Danila MI, et al. 2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis. Arthritis Rheumatol. 2023;75(12):2088-2102.
  8. 8.Youssef J, Novosad SA, Winthrop KL. Infection risk and safety of corticosteroid use. Rheum Dis Clin North Am. 2016;42(1):157-176.
  9. 9.Strand V, Cohen S, Schiff M, et al.; Leflunomide Rheumatoid Arthritis Investigators Group. Treatment of active rheumatoid arthritis with leflunomide compared with placebo and methotrexate. Arch Intern Med. 1999;159(21):2542-2550.
  10. 10.Mucke J, Simon HU, Burmester GR. The safety of antirheumatic drugs. Dtsch Arztebl Int. 2022;119(6):81-87.
  11. 11.Holdsworth E, Donaghy B, Fox KM, et al. Biologic and targeted synthetic DMARD utilization in the United States: Adelphi Real World Disease Specific Programme for Rheumatoid Arthritis. Rheum Ther. 2021;8(4):1637-1649.
  12. 12.Mohan N, Edwards ET, Cupps TR, et al. Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arth Rheum. 2001;44(12):2862-2869.
  13. 13.Rempenault C, Lukas C, Combe B, et al. Risk of diverticulitis and gastrointestinal perforation in rheumatoid arthritis treated with tocilizumab compared with rituximab or abatacept. Rheumatology (Oxford). 2022;61(3):953-962.
  14. 14.Bykerk VP, Östör AJK, Alvaro-Gracia J, et al. Long-term safety and effectiveness of tocilizumab in patients with rheumatoid arthritis and inadequate responses to csDMARDs and/or TNF inhibitors: an open-label study close to clinical practice. Clin Rheumatol. 2019;38(9):2411-2421.
  15. 15.Dalal DS, Zhang T, Shireman TI. Medicare expenditures for conventional and biologic disease modifying agents commonly used for treatment of rheumatoid arthritis. Semin Arthritis Rheum. 2020;50(5):822-826.
  16. 16.Bass AR, Chakravarty E, Akl EA, et al. 2022 American College of Rheumatology Guideline for Vaccinations in Patients With Rheumatic and Musculoskeletal Diseases. Arthritis Care Res (Hoboken). 2023;75(3):449-464.
  17. 17.Fragoulis GE, Dey M, Zhao S, et al. Systematic literature review informing the 2022 EULAR recommendations for screening and prophylaxis of chronic and opportunistic infections in adults with autoimmune inflammatory rheumatic diseases. RMD Open. 2022;8(2):e002726.
  18. 18.Grigor C, Capell H, Stirling A, et al. Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet. 2004;364(9430):263-269.
  19. 19.Aletaha D, Smolen JS. The Simplified Disease Activity Index (SDAI) and Clinical Disease Activity Index (CDAI) to monitor patients in standard clinical care. Best Pract Res Clin Rheumatol. 2007;21(4):663-675.
  20. 20.Anderson JK, Zimmerman L, Caplan L, et al. Measures of rheumatoid arthritis disease activity: Patient (PtGA) and Provider (PrGA) Global Assessment of Disease Activity, Disease Activity Score (DAS) and Disease Activity Score with 28-Joint Counts (DAS28), Simplified Disease Activity Index (SDAI), Clinical Disease Activity Index (CDAI), Patient Activity Score (PAS) and Patient Activity Score-II (PASII), Routine Assessment of Patient Index Data (RAPID), Rheumatoid Arthritis Disease Activity Index (RADAI) and Rheumatoid Arthritis Disease Activity Index-5 (RADAI-5), Chronic Arthritis Systemic Index (CASI), Patient-Based Disease Activity Score With ESR (PDAS1) and Patient-Based Disease Activity Score without ESR (PDAS2), and Mean Overall Index for Rheumatoid Arthritis (MOI-RA). Arthritis Care Res (Hoboken). 2011;63(suppl 11):S14-S36.
  21. 21.Salaffi F, Di Carlo M, Farah S, et al. Rheumatoid arthritis disease activity assessment in routine care: performance of the most widely used composite disease activity indices and patient-reported outcome measures. Acta Biomed. 2021;92(4):e2021238.
  22. 22.Beydon M, Pinto S, De Rycke Y, et al. Risk of cancer for patients with rheumatoid arthritis versus general population: a national claims database cohort study. Lancet Reg Health Eur. 2023;35:100768.
  23. 23.Wang C, de Pablo P, Chen X, et al. Acupuncture for pain relief in patients with rheumatoid arthritis: a systematic review. Arthritis Rheum. 2008;59(9):1249-1256.
  24. 24.Haaz S, Bartlett SJ. Yoga for arthritis: a scoping review. Rheum Dis Clin North Am. 2011;37(1):33-46.
  25. 25.Calder PC. Omega-3 fatty acids and inflammatory processes. Nutrients. 2010;2(3):355-374.
  26. 26.Stenström CH, Minor MA. Evidence for the benefit of aerobic and strengthening exercise in rheumatoid arthritis. Arthritis Rheum. 2003;49(3):428-434.
  27. 27.Al-Qubaeissy KY, Fatoye FA, Goodwin PC, et al. The effectiveness of hydrotherapy in the management of rheumatoid arthritis: a systematic review. Musculoskeletal Care. 2013;11(1):3-18.

Current edition

Hepatitis Overview

Hepatitis Overview

Copyright © 2026 by the American Academy of Family Physicians.

This content is owned by the AAFP. A person viewing it online may make one printout of the material and may use that printout only for his or her personal, non-commercial reference. This material may not otherwise be downloaded, copied, printed, stored, transmitted or reproduced in any medium, whether now known or later invented, except as authorized in writing by the AAFP. See permissions for copyright questions and/or permission requests.